Utility of cystatin C for assessment of renal function after cardiac surgery

Nephron - Clinical Practice

Volumn 112, Issue 2, 2009, Pages

  Heise, D ^a,b   Waeschle, R M ^a   Schlobohm, J ^a   Wessels, J ^b   Quintel, M ^a  

^a Department of Anaesthesiology Emergency and Intensive Care Medicine   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute renal failure; Cardiac surgery; Cystatin C; Glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C;

ACUTE KIDNEY FAILURE; ARTICLE; BIOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL PATIENT;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR SURGICAL PROCEDURES; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 65449154383     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213898     Document Type: Article

References (31)

1. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999;14:1158-1162.
2. Ympa YP, Sakr Y, Reinhart K, Vincent JL: Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005;118:827-832.
3. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial re-vascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128:194-203.
4. Landoni G, Zangrillo A, Franco A, Aletti G, Roberti A, Calabro MG, Slaviero G, Bignami E, Marino G: Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol 2006;23: 17-22.
5. Bent P, Tan HK, Bellomo R, Buckmaster J, Doolan L , Hart G, Silvester W, Gutteridge G, Matalanis G, Raman J, Rosalion A, Buxton BF: Early and intensive continuous hemofil-tration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-837.
6. Demirkilic U, Kuralay E, Yenicesu M, Caglar K, Oz BS, Cingoz F, Gunay C, Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H: Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004;19:17-20.
7. Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, Colar-dyn FA: Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005;20:747-753.
8. Rahn KH, Heidenreich S, Bruckner D: How to assess glomerular function and damage in humans. J Hypertens 1999;17:309-317.
9. Grubb AO: Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000; 35:63-99.
10. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum cre-atinine values. Clin Chem 2007;53:766-772.
11. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G, Christensson A: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005;51:1420-1431.
12. Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cys-tatin C assay on the Dade Behring Nephe-lometer II System. Scand J Clin Lab Invest 1999;59:1-8.
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
14. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H: Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998;58:585-592.
15. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B: Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001;38:310-316.
16. Poge U, Gerhardt T, Stoffel-Wagner B, Pal-medo H, Klehr HU, Sauerbruch T, Woitas RP: Prediction of glomerular filtration rate in renal transplant recipients: cystatin C or modification of diet in renal disease equation? Clin Transplant 2006;20:200-205.
17. Daniel JP, Chantrel F, Offner M, Moulin B, Hannedouche T: Comparison of cystatin C, creatinine and creatinine clearance vs. GFR for detection of renal failure in renal transplant patients. Ren Fail 2004;26:253-257.
18. Hojs R, Bevc S, Ekart R, Gorenjak M, Puk-lavec L: Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006;21: 1855-1862.
19. Delanaye P, Lambermont B, Chapelle JP, Gielen J, Gerard P, Rorive G: Plasmatic cys-tatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Ca re Med 2004;30:980-983.
20. Risch L, Blumberg A, Huber A: Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999;14:1991-1996.
21. Larsson A, Malm J, Grubb A, Hansson LO: Calculation of glomerular filtration rate expressed in ml/min from plasma cystatin C values in mg/l. Scand J Clin Lab Invest 2004; 64:25-30.
22. Kemperman FA, Krediet RT, Arisz L: Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 2002;91:547-558.
23. Knight EL, Verhave JC, Spiegelman D, Hil-lege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-1421.
24. Jayagopal V, Keevil BG, Atkin SL, Jennings PE, Kilpatrick ES: Paradoxical changes in cystatin C and serum creatinine in patients with hy po-and hypert hyroidism. Clin Chem 2003;49:680-681.
25. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C: Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003;63:1944-1947.
26. Risch L, Herklotz R, Blumberg A, Huber AR: Effects of glucocorticoid immunosuppres-sion on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47:2055-2059.
27. Galteau MM, Guyon M, Gueguen R, Siest G: Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001;39:850-857.
28. Klemperer JD: Thyroid hormone and cardiac surger y. Thyroid 2002;12:517-521.
29. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66:1115-1122.
30. Herrera-Gutierrez ME, Seller-Perez G, Ban-deras-Bravo E, Munoz-Bono J, Lebron-Gal-lardo M, Fernandez-Ortega JF: Replacement of 24-hour creatinine clearance by 2-hour creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med 2007;33:1900-1906.
31. Markantonis SL, Agathokleous-Kioupaki E: Can two-, four- or eight-hour urine collections after voluntary voiding be used instead of twenty-four-hour collections for the estimation of creatinine clearance in healthy subjects? Pharm World Sci 1998;20:258-263.